Medtronic Infuse Recipients Receive $8.45 Million in Settlements
The University of California, Los Angeles has agreed to pay a combined $8.45 million to two patients who received Medtronic's controversial Infuse bone graft product. These individuals filed lawsuits alleging that the product caused unwanted bone growth. They also claimed that the implanting surgeon had a conflict of interest because … [Read more...] about Medtronic Infuse Recipients Receive $8.45 Million in Settlements
Medtronic Uses Preemption in Medtronic Infuse Case, Again
The denial of review by the United States Supreme Court today in the case of Caplinger v. Medtronic, Inc., Docket No. 15-321, though it might appear to be a victory for medical device manufacturer, Medtronic, Inc., it was not. While a shallow analysis of the Supreme Court’s action in denying certiorari made it seem as if Medtronic … [Read more...] about Medtronic Uses Preemption in Medtronic Infuse Case, Again
INFUSE controversy causing continual decline in Medtronic’s market share
As more negativity surrounds the Medtronic INFUSE bone growth product, the company's market share and stock value continue to decline. According to a report from Trefis.com, a stock analysis service, the recent U.S. Senate findings that Medtronic manipulated purportedly scientific data that downplayed the risks of dangerous side … [Read more...] about INFUSE controversy causing continual decline in Medtronic’s market share
Patient Claims Medtronic Infuse, Stryker OP-1 Putty were Used Off-Label without Her Consent
A California hospital is facing scrutiny over the way patients at the facility were treated with two controversial bone growth products, Stryker’s OP-1 Putty and Medtronic Inc.'s Infuse Bone Graft. According to a report from Mass Device.com, the California Department of Public Health launched an investigation of Pomona Valley … [Read more...] about Patient Claims Medtronic Infuse, Stryker OP-1 Putty were Used Off-Label without Her Consent
Kentucky Lawsuit Alleges Off-Label Medtronic Infuse Procedure Left Woman Permanent, Disabling Nerve Damage
Medtronic Inc. and Kentucky hospital are facing lawsuit alleging that spinal surgery with the company's Infuse bone graft product left a woman total disabled. The plaintiff alleges that she received the Infuse bone graft during an “unconsented, off-label surgery” at Louisville’s Norton Hospital is 2006, and as a result, suffered … [Read more...] about Kentucky Lawsuit Alleges Off-Label Medtronic Infuse Procedure Left Woman Permanent, Disabling Nerve Damage
Medtronic Profits Down After Sprint Fidelis Defibrillator Lead Recall
Medtronic Inc., the maker of the defective Sprint Fidelis Defibrillator Lead, said its profits have slipped 2% as a result of last month's Sprint Fidelis recall. To make matters worse for the company, many are now asking if Medtronic acted quickly enough to get its faulty Sprint Fidelis Lead wires off the market. Medtronic … [Read more...] about Medtronic Profits Down After Sprint Fidelis Defibrillator Lead Recall
